Scientific publisher Nature Publishing Group (NPG) has announced that Experimental & Molecular Medicine (EMM) has re-launched on nature.com as a fully open access title. Co-published by NPG and the Korean Society for Biochemistry and Molecular Biology (KSBMB), EMM is devoted to publishing the latest and most important advances in genetic, molecular and cellular studies of human physiology and diseases.
The journal re-launches with revised aims and scope and publishes original research papers and reviews that communicate the improved clinical benefits for human health from the experimental and translational research performed using molecular tools. EMM provides a suitable platform for publishing studies involving basic discoveries with clinical relevance as well as those dealing with mechanisms, diagnosis and treatment of diseases.
The editorial team is led by Editor-in-Chief Professor Dae-Myung Jue with Professors Kyungho Choi, Sangdun Choi, Yoon-Keun Kim and Young-Han Lee as Associate Editors. A new international editorial board, composed of molecular biologists, biochemists and physicians, work with the editorial team of EMM to further define and shape the field of biomedical research.
EMM is the 15th journal published by NPG in the Asia-Pacific region, and joins over 60 journals in NPG's journal portfolio that have either an open access option or are entirely open access. 58 of its 62 academic and society publications (94%) have introduced open access options or are open access journals.
